The presence of circulating tumor cells (CTCs) during chemotherapy is a predictor of worse prognosis for patients with colorectal cancer (CRC), according to investigators in China.
The team reported that in addition to the prognostic value of CTCs, circulating tumor microemboli (CTM) and vimentin-positive CTCs, in particular, predicted poorer survival among some patients (Cancer Cell Int 2017;17:6, PMID: 28070168).
The team recruited 98 patients with advanced CRC who were undergoing chemotherapy